PDT Partners’s PDL BioPharma, Inc. PDLI Stock Holding History

PDT Partners’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-258,702	Closed	-$1.82M	–	1884
2015 Q1	$1.82M	Buy	258,702 +119,237	+85%	+$864K	0.05%	490
2014 Q4	$1.07M	Sell	139,465 -454,034	-77%	-$3.59M	0.1%	225
2014 Q3	$4.43M	Buy	+593,499	New	+$5.51M	0.11%	228
2014 Q2	–	Sell	-215,206	Closed	-$1.79M	–	1861
2014 Q1	$1.79M	Buy	+215,206	New	+$1.84M	0.04%	488
2013 Q4	–	Sell	-401,814	Closed	-$3.2M	–	1508
2013 Q3	$3.2M	Buy	401,814 +384,314	+2,196%	+$3.09M	0.09%	309
2013 Q2	$135K	Buy	+17,500	New	+$136K	﹤0.01%	1424

Other funds holding PDLI

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAM

Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PDT Partners's PDLI Position: Q2 2015 in Review

PDT Partners sold out of PDL BioPharma, Inc. (PDLI) in Q2 2015, closing a stake of 258,702 shares — an estimated $1.82M sold.

PDT Partners first reported a position in PDLI in Q2 2013 and held it in 6 quarters. The position peaked at $4.43M in Q3 2014. 204 funds tracked by Wall St. Rank hold PDLI as of Q2 2015.

PDT Partners reported no remaining PDL BioPharma, Inc. position as of Q2 2015 after selling out during the quarter.
PDT Partners sold 258,702 PDL BioPharma, Inc. shares in Q2 2015, an estimated $1.82M.
PDT Partners first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 6 quarters.
PDT Partners's PDL BioPharma, Inc. position peaked at $4.43M in Q3 2014.
204 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2015.

Based on PDT Partners's 13F filing for Q2 2015, filed 14 Aug 2015.